Coreopsis Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Hyderabad, Telangana, India, established in 2018.

2018 Hyderabad, Telangana, India Struck Off

Last Updated: July 22, 2025

About Coreopsis Pharmaceuticals Private Limited

Coreopsis Pharmaceuticals Private Limited, a struck off private limited company, was established on 05 December 2018 in Hyderabad, Telangana, India. Engaging in wholesale within the trading sector, it holds CIN: U51909TG2018PTC128770. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Salinder Singh (Director), Gulam Mohammad Malik (Director), Sheikh Tahir Rehman (Director). It is based at H.No 12-2-720/6/203 Second Floor Flat No. 203 Nanal Nagar Mehdipatnam, Hyderabad, Telangana, 500028.

Company Details

CIN/LLPIN
U51909TG2018PTC128770
Registration Number
128770
Incorporation Date
05 December 2018
Authorized Capital
₹1.00 M
Paid-Up Capital
₹1.00 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 1.00 M as on 22-07-2025
Paid Up Capital ₹ 1.00 M as on 22-07-2025
Company Age 7 Year, 2 Months

Comprehensive Company Insights

Explore comprehensive insights into Coreopsis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Coreopsis Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Salinder Singh	Director	05 Dec 2018	Current
Gulam Mohammad Malik	Director	05 Dec 2018	Current
Sheikh Tahir Rehman	Director	05 Dec 2018	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Coreopsis Pharmaceuticals.

Enhance accessibility to Coreopsis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Coreopsis Pharmaceuticals?

Unlock access to Coreopsis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Coreopsis Pharmaceuticals?

Unlock and access historical data on people associated with Coreopsis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Coreopsis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coreopsis Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Coreopsis Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Salinder Singh was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
05 Dec 2018
Director Appointment

Progress on Gulam Mohammad Malik was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was documented.
05 Dec 2018
Director Appointment

Sheikh Tahir Rehman was appointed as a Director was appointed as a Director on 05 Dec 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
05 Dec 2018
Company Incorporation

The activity Coreopsis Pharmaceuticals Private Limited was registered on 05 Dec 2018 with Roc Hyderabad & aged 7 years 2 months as per MCA records. was completed.
05 Dec 2018

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Coreopsis Pharmaceuticals Private Limited?

The CIN of Coreopsis Pharmaceuticals Private Limited is U51909TG2018PTC128770.

Where is Coreopsis Pharmaceuticals Private Limited headquartered?

Coreopsis Pharmaceuticals Private Limited is headquartered at H.No 12-2-720/6/203 Second Floor Flat No. 203 Nanal Nagar Mehdipatnam, Hyderabad, Telangana, 500028.

When was Coreopsis Pharmaceuticals Private Limited incorporated?

Coreopsis Pharmaceuticals Private Limited was incorporated on 05 December 2018.

Who are the current directors of Coreopsis Pharmaceuticals Private Limited?

The current directors of Coreopsis Pharmaceuticals Private Limited are

What is the primary industry of Coreopsis Pharmaceuticals Private Limited?

The primary industry of Coreopsis Pharmaceuticals Private Limited is Trading.

Is Coreopsis Pharmaceuticals Private Limited a listed company?

Coreopsis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Coreopsis Pharmaceuticals Private Limited?

The authorized capital of Coreopsis Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available